Pag-aaral pangklinika para sa HIV sa Houston, TX
Isang pag-aaral para sa HIV ang naghahanap ng mga kalahok sa isang site sa loob o malapit sa Houston. Buksan ito upang makita kung sino ang makakasali at kung paano makipag-ugnayan sa koponan ng pag-aaral.
Opisyal na teksto ng pag-aaral (English)
A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed
Nagre-recruitPhase 3
- GSK Investigational Site, Houston
ADELANTE: A Randomized Controlled Trial to Improve Engagement in Care for Latinos With HIV
Nagre-recruit
- Baylor College of Medicine, Houston
A Clinical Study of Islatravir and Ulonivirine for People With HIV-1 Who Have Not Been Treated Before (MK-8591B-062)
Nagre-recruitPhase 2/3
- Saint Hope Foundation, Inc. ( Site 1504), Bellaire · 7 mi ang layo
Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention
Nagre-recruitObservasyonal na pag-aaral
- UT Health, Houston
- Thomas Street at Quentin Mease Health Center, Houston
Very Early Intensive Treatment of Infants Living With HIV to Achieve HIV Remission
Nagre-recruitPhase 1/2
- 5128, Baylor College of Medicine/Texas Children's Hospital Clinical Research Site, Houston
Cytotoxic T Lymphocytes in Treating Patients With Malignancies With BK and/or JC Virus
Nagre-recruitPhase 2
- M D Anderson Cancer Center, Houston
A Clinical Trial to Look at the Safety and Immune Responses of the RNA-based Vaccine BNT168 in Adults Living With or Without HIV
Nagre-recruitPhase 1Malugod na tinatanggap ang malusog na boluntaryo
- The Crofoot Research Center, Houston
Impact of Behavior Modification Interventions and Lung Cancer Screening on Smoking Cessation in People Living With HIV: A Feasibility Study
Nagre-recruit
- University of Texas M.D. Anderson Cancer Center, Houston
Positive Peers Intervention Clinical Trial
Nagre-recruit
- Thomas Street Clinic, Houston
Screen2Prevent (S2P)
Nagre-recruitMalugod na tinatanggap ang malusog na boluntaryo
- Baylor College of Medicine, Houston
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
Nagre-recruitPhase 2
- UT Health Houston, Houston
A Phase 2b Study Evaluating Oral VH4524184 Regimens in Treatment Naïve Persons With HIV-1 (INNOVATE Study)
Nagre-recruitPhase 2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
- GSK Investigational Site, Bellaire · 7 mi ang layo
Kidney Transplantation From Donors With HIV: Impact on Rejection and Long-Term Outcomes (Expanding HOPE Kidney)
Nagre-recruit
- Houston Methodist Research Institute, Houston
Menopausal HT for Women Living With HIV (HoT)
Nagre-recruitPhase 4
- Houston AIDS Research Team CRS (31473), Houston
Assessing the Use of MY-RIDE, a Just-in-time Adaptive Intervention, to Improve HIV Prevention and Substance Use in Youth Experiencing Homelessness
Nagre-recruit
- The University of Texas Health Science Center at Houston, Houston
Cholesterol and Inflammation Lowering Via Bempedoic Acid, an ACL-inhibiting Regimen in HIV Trial (CLEAR HIV Trial)
Nagre-recruitPhase 2
- UT Health Houston, Houston
Pharmacokinetics, Safety, Tolerability of Dolutegravir/Rilpivirine in Pediatrics
Nagre-recruitPhase 1/2
- GSK Investigational Site, Houston
- GSK Investigational Site, Houston
Pag-aaral para sa HIV sa ibang lungsod
- Washington, DC22 pag-aaral
- New York City, NY18 pag-aaral
- Miami, FL17 pag-aaral
- Baltimore, MD16 pag-aaral
- San Francisco, CA15 pag-aaral
- Chicago, IL14 pag-aaral
- Atlanta, GA14 pag-aaral
- Philadelphia, PA11 pag-aaral
- Boston, MA11 pag-aaral
- San Diego, CA10 pag-aaral
- Los Angeles, CA9 pag-aaral
- Seattle, WA8 pag-aaral
Iba pang pag-aaral sa Houston
- Non-Small Cell Lung Cancer145 pag-aaral
- Kanser sa Suso126 pag-aaral
- Kanser (lahat ng uri)122 pag-aaral
- Metastatic Cancer104 pag-aaral
- Colorectal Cancer103 pag-aaral
- Kanser sa Ovary90 pag-aaral
- Acute Myeloid Leukemia86 pag-aaral
- Kanser sa Baga78 pag-aaral
- Kanser sa Prostate76 pag-aaral
- Kanser ng Endometrium69 pag-aaral
- Kanser sa Pancreas62 pag-aaral
- Melanoma59 pag-aaral
Mula sa ClinicalTrials.gov, na-kuha noong Okt 1, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.